Uveitis Clinical Trials

206 clinical trials for Uveitis across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. — RECRUITING · PHASE2
• Metagenomics for Ocular Inflammation — RECRUITING
• A Study of Uveitis in Children <18 Years of Age — RECRUITING
• RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age — RECRUITING
• Genetics of Uveitis — RECRUITING
• Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography — RECRUITING
• The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment — RECRUITING · PHASE3
• AutoInflammatory Disease Alliance Registry (AIDA) — RECRUITING
• Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study — RECRUITING · PHASE1
• Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis — RECRUITING · NA
• Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis — RECRUITING · PHASE2
• A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis — RECRUITING
• Minocycline for Chronic Autoimmune Uveitis — RECRUITING · PHASE1
• Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis — COMPLETED · PHASE2
• The use of intraocular methotrexate to treat uveitis: a safety and efficacy study — TERMINATED · PHASE4
• Intestinal Bacteria and Ocular Inflammatory Disease — COMPLETED
• Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis — NOT_YET_RECRUITING · PHASE4
• I4V-MC-JAHW: An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis — TERMINATED · PHASE3
• Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing — COMPLETED · NA
• Uveitis/Intraocular Inflammatory Disease Biobank (iBank) — COMPLETED
• A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis — ACTIVE_NOT_RECRUITING · PHASE3
• Imaging Quantification of Inflammation (IQI) — ACTIVE_NOT_RECRUITING
• Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant — COMPLETED
• Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital — COMPLETED
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis — ACTIVE_NOT_RECRUITING · PHASE3
• Wide Field OCTA in Ocular Diseases — NOT_YET_RECRUITING
• ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) — COMPLETED · PHASE2
• Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles — ACTIVE_NOT_RECRUITING · NA
• Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis — COMPLETED · PHASE2
• Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore — ACTIVE_NOT_RECRUITING
• Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis — COMPLETED · PHASE2
• Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis — COMPLETED · NA
• Characteristics of Ankylosing Spondylitis Associated Uveitis — COMPLETED
• Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis — ACTIVE_NOT_RECRUITING · NA
• Adalimumab vs. Conventional Immunosuppression for Uveitis Trial — COMPLETED · PHASE3
• Adalimumab in JIA-associated Uveitis Stopping Trial — COMPLETED · PHASE4
• Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy — ACTIVE_NOT_RECRUITING
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — TERMINATED · PHASE2
• Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) — OTHER · PHASE4
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert — TERMINATED · PHASE3
• Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects — COMPLETED · NA
• The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease — COMPLETED
• UNICORNS: Uveitis in Childhood Prospective National Cohort Study — ACTIVE_NOT_RECRUITING
• Six-months Versus Nine-months ATT for Ocular TB — COMPLETED · PHASE4
• Biomarkers in Ocular Inflammation and Uveitis — COMPLETED
• Factors Affecting Aqueous Humor Outflow Facility in Patients with Uveitis — WITHDRAWN
• The Cohort Study of Uveitis Patients — OTHER
• Nailfold Capillaroscopic Assessment in Pediatric Uveitis Patients — COMPLETED
• A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis — WITHDRAWN · PHASE1
• Lyon Uveitis Study — OTHER

Refine this search